Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients

Heterologous prime-boost: Breaking the protective immune response bottleneck of COVID-19 vaccine candidates

(2021) Qian He et al.   Emerging Microbes & Infections

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

(2021) Brian J. Boyarsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Initial Effects of COVID-19 on Patients with ESKD

(2021) Eric D. Weinhandl et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data

(2021) Robert H Shaw et al.   LANCET

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

(2021) Andreas Greinacher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

(2021) Jerald Sadoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated with Belatacept

(2021) Nathalie Chavarot et al.   TRANSPLANTATION

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

(2021) Alexandra J. Spencer et al.   Nature Communications

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

(2021) William A. Werbel et al.   ANNALS OF INTERNAL MEDICINE

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

(2021) Ilies Benotmane et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antibody titers and protection against a SARS-CoV-2 infection

(2021) Chloé Dimeglio et al.   JOURNAL OF INFECTION

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2

(2021) Matthias Tenbusch et al.   LANCET INFECTIOUS DISEASES

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

(2021) Tina Schmidt et al.   NATURE MEDICINE

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

(2021) Nassim Kamar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients

(2021) Victoria G. Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients

(2021) Saima Aslam et al.   Transplant Infectious Disease

Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept

(2021) Michael T. Ou et al.   TRANSPLANTATION

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

(2021) David Hillus et al.   Lancet Respiratory Medicine

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

(2021) Shuo Feng et al.   NATURE MEDICINE

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

(2020) David M. Weinreich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Unknown

(2016)   Transplant Infectious Disease

Unknown

(2016)   Transplant Infectious Disease

Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy

(2013) Iwijn De Vlaminck et al.   CELL

Impact of Immunosuppression on Recall Immune Responses to Influenza Vaccination in Stable Renal Transplant Recipients

(2013) Michelle Cowan et al.   TRANSPLANTATION